Suchergebnisse - "Sato, Noriko"

PubPharm (863)

101

Different AT(N) profiles and clinical progression classified by two different N markers using total tau and neurofilament light chain in cerebrospinal fluid

enthalten in: BMJ neurology open | 2022

von Kasuga, K. | Kikuchi, M. | Tsukie, T. | +109

102

Free water derived by multi-shell diffusion MRI reflects tau/neuroinflammatory pathology in Alzheimer's disease

enthalten in: Alzheimer's & dementia (New York, N. Y.) | 2022

von Nakaya, M. | Sato, N. | Matsuda, H. | +14

103

Diagnostic Yield of Chilaiditi's Sign in Advanced-Phase Late-Onset Pompe Disease

enthalten in: Journal of neuromuscular diseases | 2022

von Takahashi, J. | Mori-Yoshimura, M. | Ariga, H. | +3

104

Potential Treat-to-Target Approach for Methamphetamine Use Disorder : A Pilot Study of Adenosine 2A Receptor Antagonist With Positron Emission Tomography

enthalten in: Frontiers in pharmacology | 2022

von Okita, K. | Matsumoto, T. | Funada, D. | +5

105

In vivo availability of the cytokine IL-7 constrains the survival and homeostasis of peripheral iNKT cells

enthalten in: Cell reports | 2022

von Park, J. | Won, H. | DiPalma, D. | +8

106

Sub-GOFA : A tool for Sub-Gene Ontology function analysis in clonal mosaicism using semantic (logical) similarity

enthalten in: Bioinformation | 2022

von Katsuda, T. | Sato, N. | Mogushi, K. | +2

107

Day-by-Day Blood Pressure Variability in the Subacute Stage of Ischemic Stroke and Long-Term Recurrence

enthalten in: Stroke | 2022

von Fukuda, K. | Matsuo, R. | Kamouchi, M. | +31

108

Low EEG Gamma Entropy and Glucose Hypometabolism After Corpus Callosotomy Predicts Seizure Outcome After Subsequent Surgery

enthalten in: Frontiers in neurology | 2022

von Kosugi, K. | Iijima, K. | Yokosako, S. | +8

109

Causes of ischemic stroke in young adults versus non-young adults : A multicenter hospital-based observational study

enthalten in: PloS one | 2022

von Ohya, Y. | Matsuo, R. | Sato, N. | +7

110

Correction : Infliximab for pediatric patients with Crohn's disease: A Phase 3, open-label, uncontrolled, multicenter trial in Japan

enthalten in: PloS one | 2022

von Tajiri, H. | Motoya, S. | Kinjo, F. | +9

ErratumFor: PLoS One. 2018 Aug 16;13(8):e0201956. - PMID 30114224